Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

The impact of aspirin use on colorectal cancer patients.

Sahin IH.

Eur J Cancer. 2013 Jun;49(9):2274-5. doi: 10.1016/j.ejca.2013.02.040. Epub 2013 Mar 28. No abstract available.

PMID:
23541569
2.

Response to letter commenting on paper EJC-D-12-01401: Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.

McCowan C, Donnan PT, Munro AJ, Steele RJ.

Eur J Cancer. 2013 Jun;49(9):2273. doi: 10.1016/j.ejca.2013.03.012. Epub 2013 Mar 27. No abstract available.

PMID:
23541570
3.

Aspirin extends life of some patients with colorectal cancer.

Printz C.

Cancer. 2013 Feb 1;119(3):472-3. doi: 10.1002/cncr.27961. No abstract available.

4.

Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.

McCowan C, Munro AJ, Donnan PT, Steele RJ.

Eur J Cancer. 2013 Mar;49(5):1049-57. doi: 10.1016/j.ejca.2012.10.024. Epub 2012 Nov 19.

PMID:
23182687
5.

Adjuvant therapy for colorectal cancer--is there a place for a Northern Ireland study?

Wilson RH, Houston RF, Moorehead RJ.

Ulster Med J. 1994 Apr;63(1):44-51. Review.

6.

Aspirin, PIK3CA mutation, and colorectal-cancer survival.

Sahin IH, Garrett C.

N Engl J Med. 2013 Jan 17;368(3):289. doi: 10.1056/NEJMc1214189#SA2. No abstract available.

PMID:
23323915
7.

Aspirin, PIK3CA mutation, and colorectal-cancer survival.

Viúdez A, Hernandez I, Vera R.

N Engl J Med. 2013 Jan 17;368(3):289. doi: 10.1056/NEJMc1214189#SA1. No abstract available.

PMID:
23323914
8.

The role of aspirin in prevention and management of colorectal cancer.

Fuchs CS.

Clin Adv Hematol Oncol. 2011 Apr;9(4):330-2. No abstract available.

PMID:
21558993
9.

Aspirin cuts return of precursor to colorectal cancer.

Levenson D.

Rep Med Guidel Outcomes Res. 2003 Mar 21;14(6):7-8. No abstract available.

PMID:
12838968
10.

The role of aspirin in colorectal cancer prevention and treatment.

Chan A.

Oncology (Williston Park). 2013 Oct;27(10):1012, 1014, 1042. No abstract available.

PMID:
24367859
11.

Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas.

Asano TK, McLeod RS.

Cochrane Database Syst Rev. 2004;(2):CD004079. Review.

PMID:
15106236
12.

Postsurgical sequential methotrexate/5-FU and leucovorin on outpatient basis for advanced colorectal carcinoma.

Tokunaga Y, Kitaoka A, Yagi T, Tokuka A, Ohsumi K.

Hepatogastroenterology. 2001 Jan-Feb;48(37):128-32.

PMID:
11268947
13.

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R.

N Engl J Med. 2003 Mar 6;348(10):883-90. Erratum in: N Engl J Med. 2003 May 8;348(19):1939.

14.

Aspirin and the prevention of colorectal cancer: a review of the evidence.

Paganini-Hill A.

Semin Surg Oncol. 1994 May-Jun;10(3):158-64.

PMID:
8085092
15.

Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trial.

Scheithauer W, Kornek GV, Ulrich-Pur H, Penz M, Raderer M, Salek T, Haider K, Kwasny W, Depisch D.

Cancer. 2001 Apr 1;91(7):1264-71.

PMID:
11283925
16.

Incidence and prognosis of synchronous colorectal carcinomatosis.

Goéré D, Allard MA, Honoré C, Dumont F, Elias D.

Future Oncol. 2013 Apr;9(4):541-9. doi: 10.2217/fon.12.206. Review.

PMID:
23560376
17.

Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy.

Österlund P, Soveri LM, Isoniemi H, Poussa T, Alanko T, Bono P.

Br J Cancer. 2011 Feb 15;104(4):599-604. doi: 10.1038/bjc.2011.2. Epub 2011 Feb 8.

18.

Use and safety of aspirin in the chemoprevention of colorectal cancer.

Singh AK, Trotman BW.

J Assoc Acad Minor Phys. 1998;9(2):40-4. Review.

PMID:
9648425
19.

Hypomagnesaemia in patients with metastatic colorectal carcinoma treated with cetuximab.

Melichar B, Králíčková P, Hyšpler R, Kalábová H, Cerman J Jr, Holečková P, Studentová H, Malířová E.

Hepatogastroenterology. 2012 Mar-Apr;59(114):366-71. doi: 10.5754/hge10330.

PMID:
22353500

Supplemental Content

Support Center